NYSE:CORBF Global Cord Blood (CORBF) Stock Price, News & Analysis → POTUS in ‘25 Not Biden/Trump, But (From The Freeport Society) (Ad) Free CORBF Stock Alerts $1.20 0.00 (0.00%) (As of 06/3/2024 ET) Add Compare Share Share Today's Range$1.20▼$1.2050-Day Range$1.10▼$1.5052-Week Range$0.02▼$3.00VolumeN/AAverage Volume2,580 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsTrendsStock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsTrends Get Global Cord Blood alerts: Email Address Ad The Freeport SocietyPOTUS in ‘25 Not Biden/Trump, ButAnd I believe when they do take the oath of office, their fingers will be crossed… and America will descend into chaos.Click here now to see my urgent election warning. About Global Cord Blood Stock (NYSE:CORBF)Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2022, it operated three cord blood banks, including one in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd.Read More CORBF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CORBF Stock News HeadlinesJune 1 at 2:52 AM | americanbankingnews.comGlobal Cord Blood (NYSE:CORBF) Stock Price Up 7.1%May 30, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Global Cord Blood Corporation of Class Action Lawsuit and Upcoming Deadlines - CORBFMay 30, 2024 | prnewswire.comROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Global Cord Blood Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - CO, CORBFMay 29, 2024 | prnewswire.comCORBF Investors Have Opportunity to Lead Global Cord Blood Corporation Securities Fraud LawsuitMay 28, 2024 | prnewswire.comCORBF Investors Have Opportunity to Lead Global Cord Blood Corporation Securities Fraud LawsuitMay 28, 2024 | msn.comPrenatal exposure to 'forever chemicals' may increase obesity and hypertension risk in childrenMay 27, 2024 | stockhouse.comDEADLINE ACTION ALERT: The Schall Law Firm Encourages Investors in Global Cord Blood Corporation with Losses to Contact the FirmMay 27, 2024 | yahoo.comHow 2 debunked accounts of sexual violence on Oct. 7 fueled a global dispute over Israel-Hamas warMay 22, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Global Cord Blood Corporation of Class Action Lawsuit and Upcoming Deadlines - CORBFMay 22, 2024 | prnewswire.comCORBF Investors Have Opportunity to Lead Global Cord Blood Corporation Securities Fraud LawsuitMay 20, 2024 | prnewswire.comROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Global Cord Blood Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - CO, CORBFMay 20, 2024 | businesswire.comKirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Global Cord Blood Corporation (CORBF) InvestorsMay 16, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Global Cord Blood Corporation of Class Action Lawsuit and Upcoming Deadlines - CORBFMay 15, 2024 | prnewswire.comCORBF Investors Have Opportunity to Lead Global Cord Blood Corporation Securities Fraud LawsuitMay 14, 2024 | msn.comDoH, M42 launch region's largest hybrid cord blood bankMay 13, 2024 | prnewswire.comROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Global Cord Blood Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - CO, CORBFMay 13, 2024 | prnewswire.comCORBF Investors Have Opportunity to Lead Global Cord Blood Corporation Securities Fraud LawsuitMay 10, 2024 | prnewswire.comClass Action Alert: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against Global Cord Blood CorporationMay 7, 2024 | prnewswire.comClass Action Alert: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against Global Cord Blood CorporationMay 7, 2024 | businesswire.comDeadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Global Cord Blood Corporation (CORBF)May 6, 2024 | prnewswire.comROSEN, A LEADING LAW FIRM, Encourages Global Cord Blood Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - CO, CORBFMay 3, 2024 | businesswire.comGlancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Global Cord Blood Corporation (CORBF) InvestorsMay 2, 2024 | businesswire.comGlancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Global Cord Blood Corporation (CORBF) on Behalf of InvestorsMay 1, 2024 | businesswire.comINVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Global Cord Blood Corporation (CORBF) on Behalf of InvestorsMay 1, 2024 | forbes.comInnovationRx: FDA Approves Abbott’s Dissolvable StentsSee More Headlines Receive CORBF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Global Cord Blood and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today6/04/2024Fiscal Year End3/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Miscellaneous health & allied services, not elsewhere classified Sub-IndustryN/A Current SymbolNYSE:CORBF CUSIPN/A CIK1467808 Webwww.globalcordbloodcorp.com Phone852-3605-8180Fax852-3605-8181Employees1,202Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$196.12 million Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable Beta-0.26 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesMs. Ting Zheng (Age 52)CEO & CEO of Beijing Division Comp: $516.68kMr. Bing Chuen Chen (Age 48)Chief Financial Officer Comp: $516.68kMs. Xin Xu (Age 70)Chief Technology Officer Comp: $122.78kMs. Rui Arashiyama (Age 65)Chief Executive Officer of Guangdong & Zhejiang Divisions Comp: $257.5kMs. Cathy BaiVice President of Corporate FinanceKey CompetitorsDaVitaNYSE:DVAFresenius Medical CareNYSE:FMSSotera HealthNASDAQ:SHCagilon healthNYSE:AGLProgynyNASDAQ:PGNYView All Competitors CORBF Stock Analysis - Frequently Asked Questions How have CORBF shares performed in 2024? Global Cord Blood's stock was trading at $1.22 at the start of the year. Since then, CORBF stock has decreased by 1.6% and is now trading at $1.20. View the best growth stocks for 2024 here. How do I buy shares of Global Cord Blood? Shares of CORBF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:CORBF) was last updated on 6/4/2024 by MarketBeat.com Staff From Our PartnersPOTUS in ‘25 Not Biden/Trump, ButThe Freeport SocietyThe Only Energy Play You Should Be Looking AtWealthpin ProClaim Your Complimentary Bitcoin RewardCrypto Swap Profits[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaNvidia’s Quiet $1 Trillion PivotWeiss RatingsElon Musk’s Final Masterpiece: “X-9840”Paradigm PressMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlace[Webinar] Understanding Covered CallsOIC Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global Cord Blood Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.